P.L. van Lent

2.6k total citations
50 papers, 1.9k citations indexed

About

P.L. van Lent is a scholar working on Molecular Biology, Rheumatology and Immunology. According to data from OpenAlex, P.L. van Lent has authored 50 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 27 papers in Rheumatology and 17 papers in Immunology. Recurrent topics in P.L. van Lent's work include Osteoarthritis Treatment and Mechanisms (20 papers), S100 Proteins and Annexins (13 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). P.L. van Lent is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (20 papers), S100 Proteins and Annexins (13 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). P.L. van Lent collaborates with scholars based in Netherlands, United States and Germany. P.L. van Lent's co-authors include Wim B. van den Berg, P.M. van der Kraan, Arjen B. Blom, A. E. M. Holthuysen, Marije I. Koenders, F.A. van de Loo, Leo A. B. Joosten, Sten F.W.M. Libregts, Nico van Rooijen and M.H. van den Bosch and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

P.L. van Lent

50 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P.L. van Lent Netherlands	24	916	802	562	287	204	50	1.9k
A. Sloëtjes Netherlands	24	809 0.9×	986 1.2×	849 1.5×	293 1.0×	334 1.6×	54	2.0k
Yi He China	25	649 0.7×	707 0.9×	486 0.9×	211 0.7×	187 0.9×	88	1.9k
Hae‐Rim Kim South Korea	26	814 0.9×	600 0.7×	695 1.2×	111 0.4×	423 2.1×	128	2.1k
P A Guerne Switzerland	10	969 1.1×	343 0.4×	302 0.5×	157 0.5×	370 1.8×	17	1.8k
Birgit Niederreiter Austria	24	680 0.7×	762 1.0×	662 1.2×	63 0.2×	374 1.8×	58	1.8k
Shigeru Ishiyama Japan	15	658 0.7×	1.0k 1.3×	918 1.6×	116 0.4×	626 3.1×	22	2.4k
Harini Raghu United States	11	1.0k 1.1×	558 0.7×	288 0.5×	383 1.3×	224 1.1×	16	1.8k
Tania Silvestri Italy	19	649 0.7×	241 0.3×	279 0.5×	202 0.7×	264 1.3×	35	1.3k
Stefano Alivernini Italy	26	963 1.1×	876 1.1×	851 1.5×	61 0.2×	305 1.5×	85	2.6k
Anne Crilly United Kingdom	17	608 0.7×	395 0.5×	312 0.6×	67 0.2×	222 1.1×	34	1.4k

Countries citing papers authored by P.L. van Lent

Since Specialization

Citations

This map shows the geographic impact of P.L. van Lent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.L. van Lent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.L. van Lent more than expected).

Fields of papers citing papers by P.L. van Lent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.L. van Lent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.L. van Lent. The network helps show where P.L. van Lent may publish in the future.

Co-authorship network of co-authors of P.L. van Lent

This figure shows the co-authorship network connecting the top 25 collaborators of P.L. van Lent. A scholar is included among the top collaborators of P.L. van Lent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.L. van Lent. P.L. van Lent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ceglie, Irene Di, Arjen B. Blom, Desirée L. Bos, et al.. (2023). CD64 as novel molecular imaging marker for the characterization of synovitis in rheumatoid arthritis. Arthritis Research & Therapy. 25(1). 158–158. 5 indexed citations

Tweehuysen, Lieke, Nathan den Broeder, Noortje van Herwaarden, et al.. (2018). Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis. RMD Open. 4(1). e000654–e000654. 29 indexed citations

Bosch, M.H. van den, Arjen B. Blom, Vardit Kram, et al.. (2017). WISP1/CCN4 aggravates cartilage degeneration in experimental osteoarthritis. Osteoarthritis and Cartilage. 25(11). 1900–1911. 37 indexed citations

Rogier, Rebecca, Heather Evans‐Marin, Julia Manasson, et al.. (2017). Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis. Scientific Reports. 7(1). 15613–15613. 102 indexed citations

Beuningen, Henk M. van, E.L. Vitters, Marije I. Koenders, et al.. (2017). Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells. Cellular Signalling. 40. 190–199. 13 indexed citations

Geven, E.J., E.N. Blaney Davidson, E.L. Vitters, et al.. (2017). The role of S100A9 in pain response during experimentally induced acute synovitis. Osteoarthritis and Cartilage. 25. S380–S380. 1 indexed citations

Roeleveld, Debbie, Renoud J. Marijnissen, Birgitte Walgreen, et al.. (2017). Higher efficacy of anti-IL-6/IL-21 combination therapy compared to monotherapy in the induction phase of Th17-driven experimental arthritis. PLoS ONE. 12(2). e0171757–e0171757. 19 indexed citations

Beuningen, Henk M. van, E.L. Vitters, F.A. van de Loo, et al.. (2016). IL37 suppresses IL-1β-induced pro-inflammatory cytokine and catabolic enzyme production in primary human oa chondrocytes: protection against cartilage degradation. Osteoarthritis and Cartilage. 24. S336–S337. 1 indexed citations

Bosch, M.H. van den, Arjen B. Blom, R. Schelbergen, et al.. (2016). Alarmin S100A9 Induces Proinflammatory and Catabolic Effects Predominantly in the M1 Macrophages of Human Osteoarthritic Synovium. The Journal of Rheumatology. 43(10). 1874–1884. 56 indexed citations

10.

Munter, W. de, M.H. van den Bosch, A. Sloëtjes, et al.. (2015). High LDL levels lead to increased synovial inflammation and accelerated ectopic bone formation during experimental osteoarthritis. Osteoarthritis and Cartilage. 24(5). 844–855. 63 indexed citations

11.

Bosch, M.H. van den, Tina M. Kilts, E.N. Blaney Davidson, et al.. (2015). WISP1 aggravates osteoarthritis by modulation of TGF-beta signaling and positive regulation of canonical Wnt signaling. Osteoarthritis and Cartilage. 23. A44–A45. 3 indexed citations

12.

Metselaar, Josbert M., Danny Gerrits, P.L. van Lent, et al.. (2015). [ 18 ]F FDG PET/CT imaging to monitor the therapeutic effect of liposome-encapsulated prednisolone in experimental rheumatoid arthritis. Journal of Controlled Release. 209. 20–26. 21 indexed citations

13.

Bosch, M.H. van den, Arjen B. Blom, A. Sloëtjes, et al.. (2015). Induction of Canonical Wnt Signaling by Synovial Overexpression of Selected Wnts Leads to Protease Activity and Early Osteoarthritis-Like Cartilage Damage. American Journal Of Pathology. 185(7). 1970–1980. 54 indexed citations

14.

Vries, Teun J. de, Ton Schoenmaker, Lilyanne C. Grevers, et al.. (2014). M‐CSF Priming of Osteoclast Precursors Can Cause Osteoclastogenesis‐Insensitivity, Which Can be Prevented and Overcome on Bone. Journal of Cellular Physiology. 230(1). 210–225. 40 indexed citations

15.

Schelbergen, R., W. de Munter, M.H. van den Bosch, et al.. (2014). Alarmins S100A8/S100A9 stimulate osteophyte formation in experimental osteoarthritis and predict osteophyte progression in the check cohort of early human osteoarthritis patients. Osteoarthritis and Cartilage. 22. S303–S303. 2 indexed citations

16.

Bosch, M.H. van den, F.A. van de Loo, E.N. Blaney Davidson, et al.. (2014). WNT and WISP1 expression in the synovium induces production of cartilage-degrading metalloproteinases by synovial cells. Osteoarthritis and Cartilage. 22. S447–S448. 1 indexed citations

17.

Schelbergen, R., et al.. (2013). Liposomal Targeting of Prednisolone Phosphate to Synovial Lining Macrophages during Experimental Arthritis Inhibits M1 Activation but Does Not Favor M2 Differentiation. PLoS ONE. 8(2). e54016–e54016. 41 indexed citations

18.

Lent, P.L. van, M.H. van den Bosch, H. Cats, et al.. (2013). Transcriptomics on synovial specimen of early human (check) and experimental OA to identify pathways and processes associated with cartilage damage. Osteoarthritis and Cartilage. 21. S42–S43. 1 indexed citations

19.

Abdollahi‐Roodsaz, Shahla, Leo A. B. Joosten, Monique M. Helsen, et al.. (2008). Shift from toll‐like receptor 2 (TLR‐2) toward TLR‐4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR‐4–mediated interleukin‐17 production. Arthritis & Rheumatism. 58(12). 3753–3764. 80 indexed citations

20.

Berg, Wim B. van den, F.A. van de Loo, P.L. van Lent, & Leo A. B. Joosten. (1993). Mechanisms of Cartilage Destruction in Joint Inflammation. Birkhäuser Basel eBooks. 39. 49–60. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact